Table II.
Complication | Number affected (%) |
---|---|
Disease progression | 29 (20.6) |
Bone marrow toxicity | 20 (14.2) |
Dysphagia | 1 (0.7) |
Cerebral hemorrhage | 1 (0.7) |
Cardiac arrest (unrelated) | 1 (0.7) |
Heart failure (unrelated) | 1 (0.7) |
Total | 53 (37.6) |
TMZ, temozolomide.